Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
about
Tumor necrosis factor-alpha and muscle wasting: a cellular perspectiveMalnutrition and Gut Flora Dysbiosis: Specific Therapies for Emerging Comorbidities in Heart FailureThe Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.Immune and neurohormonal pathways in chronic heart failure.Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight lossTNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscleBody mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trialAbdominal circumference and recurrent hospitalizations may affect the clinical outcome of patients with acute heart failureFatigue is associated with high circulating leptin levels in chronic hepatitis C.Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives.Obesity and cardiovascular risk: the new public health problem of worldwide proportions.Adiponectin protects against the development of systolic dysfunction following myocardial infarction.Counteracting muscle wasting in HIV-infected individuals.Primary and secondary prevention of heart failure with statins.Cardiac cachexia at a glance.Moderate-Intensity Exercise Improves Body Composition and Improves Physiological Markers of Stress in HIV-Infected Men.Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength.The obesity paradox in men with coronary heart disease and heart failure: the role of muscle mass and leptin.Potential of adiponectin as a cardioprotective agent.Age-associated remodeling of neural and nonneural thymic catecholaminergic network affects thymopoietic productivity.The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot studyIFN-gamma does not mimic the catabolic effects of TNF-alpha.Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting.Inflammation and perturbation of the l-carnitine system in heart failure.Post-resistance exercise ingestion of milk protein attenuates plasma TNFα and TNFr1 expression on monocyte subpopulations.Withania somnifera modulates cancer cachexia associated inflammatory cytokines and cell death in leukaemic THP-1 cells and peripheral blood mononuclear cells (PBMC's).Tumor necrosis factor-alpha and malnutrition-induced inhibition of diaphragm fiber growth in young rats.
P2860
Q24806646-2697E404-4958-4EB9-A51B-29C50B80073DQ26780506-1FD44C4E-69C3-4D74-BD3D-C59629865BB2Q34483183-E016B1EA-CC43-4670-938A-08C47CB1F728Q34513186-DD8E9BEB-983D-4153-9D26-40A09B6E2B26Q34986366-4EA90A3A-CA89-48D2-93E3-A7A6F4105D3FQ34997547-F50BDEAC-4CCE-4FC8-8523-AACCBDAEFE83Q34999484-46BB1A45-335F-41C6-93B4-F90ECC0A2DE5Q35078040-61CCF09E-5279-427F-B1D4-CDE1D9C01197Q35594907-6AA4A15C-9A8A-4077-99A9-2AAE481B07B4Q35706837-3A0D5807-E2B6-45B9-ABAC-1D7A6BF93780Q35777356-63F4DF2F-D6F2-4649-8A37-562BA75BA2D2Q36004798-1DC48CF0-7C9C-4C5F-833C-ECAA4437DF15Q36582724-3869A3C4-401C-44AF-96C9-567084FFC1F0Q36686069-BCC26F6F-8E35-44B9-A883-3ACA593E1736Q36836579-932E0C7B-AB9F-43D6-9F04-9EBB6AB2ADDAQ37156629-CCFB9C87-3BC4-42DB-9786-A3AE9EE12B62Q37381535-144AE988-9187-4D07-ACBD-194B1B3A7FCAQ37539890-4EDC008E-573F-4AA5-9582-5697C2F40677Q37608586-DA1AA736-37D8-4426-ABD9-E18D3C79C0ACQ37939602-4D94CC9D-6698-4F9B-AC4E-83582AC8BFA4Q38492490-B1A7CEB6-81A4-4455-890D-3554BBCC77F1Q40069451-E15FE6A4-A4BF-41EE-9813-C19605984A44Q40891663-256D9D49-ADE9-43A7-B4DD-B7283DF665D6Q46755079-E08E5AF3-7B3C-49D0-AD4F-FD75F9D853AFQ48364154-ACBA2034-3AE7-42BB-8DFE-56E28EBC46CFQ52327749-ED48A8F9-297D-4419-938B-6712873CD6C1Q53667372-4FE0E0CD-6474-49B9-B115-53B3BAF9962B
P2860
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
@ast
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
@en
type
label
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
@ast
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
@en
prefLabel
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
@ast
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
@en
P1476
Insights into the pathogenesis of chronic heart failure: immune activation and cachexia.
@en
P2093
Rauchhaus M
P304
P356
10.1097/00001573-199905000-00004
P577
1999-05-01T00:00:00Z